Bryan Mohally Member of the Innovation Taskforce

(VP Supply Chain Johnson & Johnson)

Introductions

The global opportunity

The opportunity for Ireland

National Vision & Strategy

Innovation Taskforce deliverables to date

Johnson & Johnson Campus Ireland

Introductions

The global opportunity

The opportunity for Ireland

National Vision & Strategy

Innovation Taskforce deliverables to date

Aging DemographicsTowards

Personalised Medicine

Convergence

Patent Expiry

Low Product Pipelines

Reduce time to market and costs

without compromising

quality

Pricing Pressures

Advances in Technologies

Pressures on Public R&D Investments

Informed Consumers

Regulation

2010 2016 CAGR

Pharmaceuticals & Biopharma US$775Bn* US$926 Bn* 5%

Medical Technologies US$347 Bn* US$607 Bn* 13%

Source: IMS Healthcare

25.3

30.4

37.7

34.035.2

38.336.4

40.0 40.7

44.5

-

5

10

15

20

25

30

35

40

45

50

2000 2001 2002 2003 2004 2005 2006 2007 2008 2009

Bn

s

LifeSciences - Exports

39.341.0

42.4 42.8

48.750.0

51.9 52.3 52.450.9

0

10

20

30

40

50

60

2000 2001 2002 2003 2004 2005 2006 2007 2008 2009

Em

p. 0

00's

LifeSciences - Employment

Source: Medical Devices, Forfás, 2010, ABSEIPharma/Bio, CSO, 2000 QNHS and External Trade Data

Source: Medical Devices, Forfás, 2010, ABSEI

3.13

4.33 4.67

5.31 5.40

5.98

5.10

5.59

6.18

6.75

-

1

2

3

4

5

6

7

2000 2001 2002 2003 2004 2005 2006 2007 2008 2009

bn

s

Medical Devices - Exports

15.4

16.5 17.3

18.6 19.4

21.8 22.0 22.1 23.0 23.0

0

5

10

15

20

25

2000 2001 2002 2003 2004 2005 2006 2007 2008 2009

Em

p. 0

00's

Medical Devices - Employment

Business Sector R&D Expenditure, current prices, 1995-2008

Source: Forfás, 2009, Research and Development Statistics at a Glance

Investments in R&D and Commercialisation Infrastructures

Red Bio

Pharma

Functional Foods

Medical Technologies

ICT

Health Life Sciences

EI

Teagasc

HRB

Life Sciences

Dept. of Health & Children

Dept. of Education & Science

Regulatory Bodies & Agencies

Enterprise Development &

Training Agencies

Science, Technology, & Innovation

(STI)FAS

IMB

Dept. of Enterprise, Trade & Employment

Dept. of Agriculture, Fisheries & FoodSFIForfás IDA

ASC

Innovation Task Force

IRCSET IRCHSS

Bord Bia

HSE

HRG

Industry Bodies & Representative Organisations

IPPOSI

PharmaChemical Ireland

IMO

FDII

IBIA

IMDA

IPHAINO

FSAI

HIQANSAI

Dept. of Taoiseach

IP Implementation

Group

Complex EcoSystem

IBEC & Relevant Sectors

ICT Ireland

ISA

IMSTA

Life Sciences

Dept. of Health & Children

Dept. of Education & Science

Regulatory Bodies & Agencies

Enterprise Development &

Training Agencies

Science, Technology, &

Innovation

(STI)

Dept. of Enterprise, Trade & Employment

Industry Organisations

Hospital & Healthcare System

Introductions

The global opportunity

The opportunity for Ireland

National Vision & Strategy

Innovation Taskforce deliverables to date

Building Irelands Smart Economy December 2008

Building the Ideas Economy - Creating

'The Innovation Island'

Securing the Enterprise

Economy and Restoring

Competitiveness

Enhancing the Environment and Securing Energy

Supplies

Investing in Critical

Infrastructure

Efficient and Effective Public

Services and Smart Regulation

Group 1: Incentives, intellectual property and venture capital:

Group 2: Commercialisation, technology transfer and converging technologies

Group 3: Achieving the Innovation Island - how to position and promote Ireland as the innovation island.

Group 4: International Innovation Development Hub (Dublin)

Batt O Keeffe TD, Minister for Enterprise, Trade and Innovation [Chairman]Lionel Alexander, Member of the Innovation Taskforce, Chair of Enterprise Feedback Group, Vice-President and General Manager, Hewlett Packard (Manufacturing) LtdAidan Brady, CEO, Citibank IrelandNed Costello, Member of the Innovation Taskforce, CEO of the Irish Universities Association Aidan Fitzsimons, Member of Enterprise Feedback Group, Dairygold Cooperative SocietyChris Horn, member of the Innovation Taskforce, Co-founder and former CEO of Iona TechnologiesBrian Kelly, Member of the Innovation Taskforce, Founder and CEO Celtic CatalystBryan Mohally, Member of the Innovation Taskforce, Vice-President Supply Chains Operations Europe, Johnson & JohnsonDr Cian Ó Mathúna, Head of Microsystems Research, Tyndall National Institute, CorkAnna Scally, Member of the Innovation Taskforce, Partner, KPMG Departments/agenciesKevin Cardiff, Secretary General, Department of FinanceSeán Gorman, Secretary General, Department of Enterprise, Trade and InnovationDermot McCarthy, Secretary General, Department of An TaoiseachBrigid McManus, Secretary General, Department of Education and SkillsAidan Dunning, Secretary General, Department of Communications, Energy and Natural ResourcesMartin Shanahan, CEO, Forfás

Innovation Taskforce Implementation Committee

Actively market Ireland as a centre of excellence for

innovation

Take advantage of new opportunities

Support our innovators and entrepreneurs

Attract new Foreign Direct

Investment and transform existing

activities

Make it easier to identify and access

IP

Strenghten links between education

and industry

Increase the availability of VC

Ensure we have a world class physical

infrastructure

Ensure we have a world class physical

infrastructure

Build on our investment to date in

Research Development

Build on our investment to date in

Research Development

Ensure that our education system

promotes education and creativity

Ensure that our education system

promotes education and creativity

Innovation Taskforce Success to date (1)

Actively market Ireland as a centre of excellence for

innovation

Take advantage of new opportunities

Support our innovators and entrepreneurs

Attract new Foreign Direct Investment

and transform existing activities

Innovation Ireland Brand

All State agencies and HEIs need to market jointly and brand Ireland as a leading innovation location and destination of choice for European and other overseas investors. We need to fully utilise the willingness of the Diaspora to contribute.

Convergence

A team from the key agencies should be formed to ensure that we take full advantage of new opportunities in convergence.

R&D Tax

R&D Tax credit offset options should be expanded. Consider modifications to the R&D Tax Credit Regime which would be of benefit to SMEsRemove incremental

base requirement

Make it easier to identify and access

IP

Strenghten links between education

and industry

Increase the availability of VC

Intellectual Property

Develop and publish a national IP Protocol which establishes ground rules which must be followed when agreeing terms around ownership of and access to all State supported IP.Convene an expert group of representatives from Industry, the VC sector, HEIs, the legal profession, and the public sector, who are informed by TT structures internationally, to rec

Innovation Fund

Attracting top-tier venture partners from abroad to Ireland is a priority and can best be achieved through implementation as soon as possible of the Innovation Fund - Ireland, envisaged in Building Ireland s Smart Economy.

Innovation Taskforce Success to date (2)

Clinical engagement

Stimulate increased participation by clinicians in translational medicineStreamline &

Support ethics

Research Funding

Improved co-ordination required between all the Irish public agencies that manage research funding, to ensure optimum Value and targeted funding

Mathemtathical skills

Incentives such as the awarding by HEIs of CAO bonus points on a pilot basis starting with Leaving Certificate 2012

Medical Device Biodesign

Agree a national agenda and roadmap for product design and development

Ensure we have a world class physical

infrastructure

Ensure we have a world class physical

infrastructure

Build on our investment to date in

Research Development

Build on our investment to date in

Research Development

Ensure that our education system

promotes education and creativity

Ensure that our education system

promotes education and creativity

Innovation Taskforce Success to date (3)

Maximising Ireland s Strengths in the Health LifeSciences

Health Research

Group

LifeSciences Alliance

Life Sciences

Dept. of Health & Children

Dept. of Education & Science

Regulatory Bodies & Agencies

Enterprise Development &

Training Agencies

Science, Technology, &

Innovation

(STI)

Dept. of Enterprise, Trade & Employment

Industry Organisations

Hospital & Healthcare System

Convergent Technology Center of Excellence

Campus Phase III .. Convergent Technologies

Complete Product Development

Lifecycle

Leverage Existing Operational Capability

Technology Platform Capability

Integrated Campus Model

Opportunity for external R&D collaboration plus financial incentives